"Caresyntax Raises $180M for Expansion of Precision Surgery Platform"

Caresyntax Raises $180M in Series C Funding

Caresyntax secures $180M in Series C Funding

Caresyntax (Linkedin), a leader in precision surgery platforms, has raised an impressive $180M in Series C funding. With a focus on advanced surgical data analytics, Caresyntax is poised to transform patient outcomes and operational efficiency in the healthcare industry.

Funding Amount: $180 million

Industry: Hospitals and Health Care

Employee Count: 51-200

CEO: Dennis Kogan (CEO Linkedin)

What Caresyntax needs to buy: Caresyntax is seeking technology partnerships, marketing and sales support, and research and development collaborations. Companies specializing in AI, data analytics, surgical technologies, and research institutions are ideal partners to help Caresyntax further enhance their precision surgery platform and expand their market presence.